Related references
Note: Only part of the references are listed.miR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by silencing neuropilin 1
Yi-Ying Wu et al.
ANGIOGENESIS (2014)
Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens
Torsten Nielsen et al.
BMC CANCER (2014)
Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c
M. K. Nygren et al.
BRITISH JOURNAL OF CANCER (2014)
Genomic Prostate Cancer Classifier Predicts Biochemical Failure and Metastases in Patients After Postoperative Radiation Therapy
Robert B. Den et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Biochemical and clinical outcomes after high-dose salvage radiotherapy as monotherapy for prostate cancer
Angela Botticella et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
hsa-miR-4516 Mediated Downregulation of STAT3/CDK6/UBE2N Plays a Role in PUVA Induced Apoptosis in Keratinocytes
Shruti Chowdhari et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1
Y. Shang et al.
ONCOGENE (2014)
miR-34a is an Intracellular and Exosomal Predictive Biomarker for Response to Docetaxel with Clinical Relevance to Prostate Cancer Progression
Claire Corcoran et al.
PROSTATE (2014)
Circulatory miR-628-5p is downregulated in prostate cancer patients
Anvesha Srivastava et al.
TUMOR BIOLOGY (2014)
被撤回的出版物: MicroRNA-320 inhibits osteosarcoma cells proliferation by directly targeting fatty acid synthase (Retracted article. See April, 2017)
Chi Cheng et al.
TUMOR BIOLOGY (2014)
Potential Urinary miRNA Biomarker Candidates for the Accurate Detection of Prostate Cancer among Benign Prostatic Hyperplasia Patients
Taha A. Haj-Ahmad et al.
JOURNAL OF CANCER (2014)
Strain-specific suppression of microRNA-320 by carcinogenic Helicobacter pylori promotes expression of the antiapoptotic protein Mcl-1
Jennifer M. Noto et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Screening of MicroRNA in Patients with Esophageal Cancer at Same Tumor Node Metastasis Stage with Different Prognoses
Bao-Sheng Zhao et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Analytical validation of the Oncotype DX prostate cancer assay - a clinical RT-PCR assay optimized for prostate needle biopsies
Dejan Knezevic et al.
BMC GENOMICS (2013)
MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway
I-Shan Hsieh et al.
CARCINOGENESIS (2013)
MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease Controls
Ang Li et al.
CLINICAL CANCER RESEARCH (2013)
MicroRNA Signature Helps Distinguish Early from Late Biochemical Failure in Prostate Cancer
Zsuzsanna Lichner et al.
CLINICAL CHEMISTRY (2013)
miQA novel microRNA based diagnostic and prognostic tool for prostate cancer
Olivia Larne et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer
Zishu Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Aberrant expression of microRNAs in bladder cancer
Hirofumi Yoshino et al.
NATURE REVIEWS UROLOGY (2013)
Distinct microRNA Expression Profile in Prostate Cancer Patients with Early Clinical Failure and the Impact of let-7 as Prognostic Marker in High-Risk Prostate Cancer
Maria Schubert et al.
PLOS ONE (2013)
Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy
Nicholas Erho et al.
PLOS ONE (2013)
Links between the Oncoprotein YB-1 and Small Non-Coding RNAs in Breast Cancer
Cherie Blenkiron et al.
PLOS ONE (2013)
Molecular Pathways and Functional Analysis of miRNA Expression Associated with Paclitaxel-Induced Apoptosis in Hepatocellular Carcinoma Cells
H. Yan et al.
PHARMACOLOGY (2013)
MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma
Xiaotang Yu et al.
TUMOR BIOLOGY (2013)
NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer
Yihui Fan et al.
PROTEIN & CELL (2013)
The Diagnostic and Prognostic Role of microRNA in Colorectal Cancer - a Comprehensive review
Haggi Mazeh et al.
JOURNAL OF CANCER (2013)
Comprehensive microRNA Profiling of Prostate Cancer
Beatriz A. Walter et al.
JOURNAL OF CANCER (2013)
MicroRNAs in prostate cancer
Won Tae Kim et al.
PROSTATE INTERNATIONAL (2013)
miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs
Muhammad Riaz et al.
BREAST CANCER RESEARCH (2013)
Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma
Qingna Zhai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Profiling of microRNAs in exosomes released from PC-3 prostate cancer cells
Nina Pettersen Hessvik et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2012)
An integrated analysis of miRNA and gene copy numbers in xenografts of Ewing's sarcoma
Neda Mosakhani et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Genetic Variation That Predicts Platinum Sensitivity Reveals the Role of miR-193b* in Chemotherapeutic Susceptibility
Dana Ziliak et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320
A. Bronisz et al.
NATURE CELL BIOLOGY (2012)
Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer
E. S. Martens-Uzunova et al.
ONCOGENE (2012)
Analysis of miRNA and mRNA Expression Profiles Highlights Alterations in Ionizing Radiation Response of Human Lymphocytes under Modeled Microgravity
Cristina Girardi et al.
PLOS ONE (2012)
A Multiplex Assay to Measure RNA Transcripts of Prostate Cancer in Urine
Sue-Ing Quek et al.
PLOS ONE (2012)
MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics
A. Gordanpour et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2012)
Protein-Coding and MicroRNA Biomarkers of Recurrence of Prostate Cancer Following Radical Prostatectomy
Qi Long et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
mRNA transcript quantification in archival samples using multiplexed, color-coded probes
Patricia P. Reis et al.
BMC BIOTECHNOLOGY (2011)
MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis
Wen Gao et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Identification of miRs-143 and-145 that Is Associated with Bone Metastasis of Prostate Cancer and Involved in the Regulation of EMT
Xinsheng Peng et al.
PLOS ONE (2011)
Reduced Expression of Brain-Enriched microRNAs in Glioblastomas Permits Targeted Regulation of a Cell Death Gene
Rebecca L. Skalsky et al.
PLOS ONE (2011)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
Suitable reference genes for relative quantification of miRNA expression in prostate cancer
Annika Schaefer et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2010)
Reprogramming of miRNA networks in cancer and leukemia
Stefano Volinia et al.
GENOME RESEARCH (2010)
Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis
Jian-Jun Zhao et al.
CHILDS NERVOUS SYSTEM (2009)
MicroRNA Profiling and Head and Neck Cancer
Xiqiang Liu et al.
COMPARATIVE AND FUNCTIONAL GENOMICS (2009)
Profiling of molecular pathways regulated by microRNA 601
Hiroaki Ohdaira et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2009)
miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation
Dale G. Schaar et al.
EXPERIMENTAL HEMATOLOGY (2009)
The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma
Lei Chen et al.
JOURNAL OF HEPATOLOGY (2009)
Ionizing radiation-induced NF-κB activation requires PARP-1 function to confer radioresistance
S. J. Veuger et al.
ONCOGENE (2009)
Epigenetic Silencing of MicroRNA miR-107 Regulates Cyclin-Dependent Kinase 6 Expression in Pancreatic Cancer
Kwang-Hyuck Lee et al.
PANCREATOLOGY (2009)
A novel and universal method for microRNA RT-qPCR data normalization
Pieter Mestdagh et al.
GENOME BIOLOGY (2009)
Diagnostic and prognostic microRNAs in stage II colon cancer
Troels Schepeler et al.
CANCER RESEARCH (2008)
Direct multiplexed measurement of gene expression with color-coded probe pairs
Gary K. Geiss et al.
NATURE BIOTECHNOLOGY (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis
Li-Xu Yan et al.
RNA (2008)
Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a European Multicenter survey of 1,296 patients
Matthias May et al.
JOURNAL OF UROLOGY (2007)
MicroRNA targeting specificity in mammals: Determinants beyond seed pairing
Andrew Grimson et al.
MOLECULAR CELL (2007)
Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin tables) based on cases from 2000 to 2005
Danil V. Makarov et al.
UROLOGY (2007)
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
Andrew J. Stephenson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer update panel report and recommendations for a standard in the reporting of surgical outcomes
Michael S. Cookson et al.
JOURNAL OF UROLOGY (2007)
Guideline for the management of clinically localized prostate cancer: 2007 update
Ian Thompson et al.
JOURNAL OF UROLOGY (2007)
Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy
Matthew R. Cooperberg et al.
CANCER (2006)
Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
Andrew J. Stephenson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Biochemical recurrence after localized treatment
Christopher L. Amling
UROLOGIC CLINICS OF NORTH AMERICA (2006)
NF-κB modulation and ionizing radiation:: mechanisms and future directions for cancer treatment
N Magné et al.
CANCER LETTERS (2006)
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
AJ Stephenson et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The University of California, San Francisco cancer of the prostate risk assessment score: A straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy
MR Cooperberg et al.
JOURNAL OF UROLOGY (2005)
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
JI Epstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
R Edgar et al.
NUCLEIC ACIDS RESEARCH (2002)
Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium
AW Partin et al.
UROLOGY (2001)
Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: Continued rise of biochemical failure after 5 years
CL Amling et al.
JOURNAL OF UROLOGY (2000)
Time-dependent ROC curves for censored survival data and a diagnostic marker
PJ Heagerty et al.
BIOMETRICS (2000)
Combination of the preoperative PSA level, biopsy Gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer
AV D'Amico et al.
UROLOGY (2000)